Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05840289
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-06
First Post:
2023-04-21
Brief Title:
A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma
Sponsor:
University Hospital Geneva
Organization:
University Hospital Geneva
Organization Data
Organization:
University Hospital Geneva
Class:
OTHER
Study ID:
2020-01659
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Geneva
Lead Sponsor Class:
OTHER
Responsible Party:
Noémie Lang
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University Hospital Geneva
Old Name:
None
Old Organization:
None